激进分子称：贸易相关的知识产权方面(Trips)必须包括对缺
NEW YORK (Reuters Health) - Global agreements on intellectual property must include a means for even the least-developed nations--those that lack the capacity to produce their own generic drugs--to gain access to copies of patented medicines during national emergencies, activists said on Tuesday.
Much has been made of the need to ensure that developing countries can override patents and produce affordable copies of proprietary drugs during heath crises. But another set of concerns exists for countries that are so poor that they lack the ability to manufacture generics, Health GAP Coalition's Asia Russell said during a briefing held by Doctors Without Borders.
Russell stressed that the very poorest countries must be permitted to import generic versions of patented drugs from countries with the ability to produce them--something she said it is not currently clear they are permitted to do. She spoke as the World Trade Organization heads into talks on its Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement this week in Qatar.
"This is a very key and technical clarification that was part of the reason for the birth of these talks last spring and the [United States Trade Representative] has squarely said--in quite an arrogant fashion, I would say--that this is a clarification that will not increase access to drugs for poor countries...and that this doesn't need to be brought up until the end of 2002 at the earliest," Russell said.
The advocacy groups represented at Tuesday's briefing support a proposal by a coalition of 60 nations, including Brazil, India and Thailand, that a declaration be adopted specifying that it is permissible to export generic versions of patented drugs to countries in dire need., 百拇医药
Much has been made of the need to ensure that developing countries can override patents and produce affordable copies of proprietary drugs during heath crises. But another set of concerns exists for countries that are so poor that they lack the ability to manufacture generics, Health GAP Coalition's Asia Russell said during a briefing held by Doctors Without Borders.
Russell stressed that the very poorest countries must be permitted to import generic versions of patented drugs from countries with the ability to produce them--something she said it is not currently clear they are permitted to do. She spoke as the World Trade Organization heads into talks on its Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement this week in Qatar.
"This is a very key and technical clarification that was part of the reason for the birth of these talks last spring and the [United States Trade Representative] has squarely said--in quite an arrogant fashion, I would say--that this is a clarification that will not increase access to drugs for poor countries...and that this doesn't need to be brought up until the end of 2002 at the earliest," Russell said.
The advocacy groups represented at Tuesday's briefing support a proposal by a coalition of 60 nations, including Brazil, India and Thailand, that a declaration be adopted specifying that it is permissible to export generic versions of patented drugs to countries in dire need., 百拇医药